BMS Joins the In Vivo Cell Therapy Chase With $1.5B Orbital Therapeutics Acquisition
Startup Orbital Therapeutics brings Bristol Myers Squibb an in vivo cell therapy in development for…
BMS Joins the In Vivo Cell Therapy Chase With $1.5B Orbital Therapeutics Acquisition
Startup Orbital Therapeutics brings Bristol Myers Squibb an in vivo cell therapy in development for treating autoimmune disease. With the deal, BMS joins AstraZeneca, AbbVie, and Gilead Sciences in turning to M&A as a way to get in vivo cell therapy assets and technologies. The post BMS Joins the In Vivo Cell Therapy Chase With…
Redesigning Healthcare: How Accessible Data Leads to Better Care
Value-based care promises to right the wrongs of fee-based healthcare. But today, we’re a long way from a value-based system. One way to get there faster? Prioritize access to data. The post Redesigning Healthcare: How Accessible Data Leads to Better Care appeared first on MedCity News.
Creating Stability Through Change: Embedding Succession Planning in Healthcare Culture
Without structured succession strategies, organizations risk instability, operational disruptions, and over-reliance on interim leadership. Here are some strategies to safeguard the future of hospitals and health systems. The post Creating Stability Through Change: Embedding Succession Planning in Healthcare Culture appeared first on MedCity News.
Parents Can and Should Be Active Participants in Autism Therapy
One in every 31 children is diagnosed with some form of autism today, up from previous years — and regardless of why we have more cases, the more pressing question is how we should address the dramatic increase in support needs. The post Parents Can and Should Be Active Participants in Autism Therapy appeared first…
Journalists Dig Into Government Shutdown and Rural Doctor Drought
KFF Health News chief Washington correspondent Julie Rovner appeared on CNN’s “Quest Means Business” to discuss the Affordable Care Act subsidies at the core of the government shutdown on Oct. 2. Rovner also appeared on NPR’s “Morning Edition” to discuss the subsidies on Oct. 7. Click here to watch Rovner on “Quest Means Business.” Click…
Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup Arbor
Chiesi Global Rare Diseases is committing up to $115 million to begin a collaboration on Arbor Biotechnologies’ in vivo gene-editing therapy for primary hyperoxaluria type 1, an inherited liver disorder. It’s the rare disease company’s first foray into genetic medicines. The post Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup…
Top-Rated Luxury 62+ Communities in Central Pennsylvania
[Sponsored] Choosing where to retire is a deeply personal decision, but the options across central Pennsylvania make it easier than ever to find your perfect fit. The post Top-Rated Luxury 62+ Communities in Central Pennsylvania appeared first on MedCity News.
As Trump Denies Climate Change, At Least 170 Hospitals Face Major Flood Risk
In West Virginia’s capital of Charleston, where about 50,000 people live in a wide, flat river valley, an intense storm has the potential to flood five of the city’s six hospitals at once. At the largest hospital, as much as 5 feet of water could reach the emergency room. At the children’s hospital, the river…
Hospitals & Clinics Still Paid Unequally for Same Care, Research Shows
A new Trilliant Health report revealed wide disparities in provider payments, with academic medical centers and certain payer-affiliated clinics receiving far higher reimbursements than their peers for the same services. The findings emphasize just how much opaque pricing practices continue to drive inequities in the U.S. healthcare system. The post Hospitals & Clinics Still Paid…
Senators Press Deloitte, Other Contractors on Errors in Medicaid Eligibility Systems
Senators have launched an inquiry into companies paid billions in taxpayer dollars to build eligibility systems for Medicaid, expressing concern that error-riddled technology and looming work requirements “will cause Americans to lose Medicaid coverage to this bureaucratic maze.” The letters, dated Oct. 10, were sent to four companies and follow a KFF Health News investigation…
